Changes of left ventricular remodeling due to increased afterload in patients with essential hypertension

Mareomi Hamada1, Akiyoshi Ogimoto1, Takashi Otani2

  • 1Division of Cardiology, Uwajima City Hospital, 1-1, Goten-machi, Uwajima, Ehime 798-8510, Japan.

Insights

Afterload mismatch, a condition where the heart works harder than it should, does not occur in early essential hypertension (EHT) without left ventricular hypertrophy (LVH). It develops in advanced EHT with LVH and heart failure due to depleted preload reserve.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Heart Failure Studies

Background:

  • Essential hypertension (EHT) and its impact on left ventricular hypertrophy (LVH) require further clarification regarding afterload mismatch.
  • The transition point of LVH between preserved and reduced systolic function in hypertensive patients is not well understood.

Purpose of the Study:

  • To investigate the occurrence of afterload mismatch in the initial stages of essential hypertension.
  • To clarify the relationship between left ventricular hypertrophy and systolic function in hypertensive individuals.

Main Methods:

  • Studied 140 EHT patients (3 groups: no LVH, LVH, LVH with heart failure) and 45 controls.
  • Measured electrocardiographic and echocardiographic parameters, including relative wall thickness (RWT), LV mass (LVM) index, and peak systolic wall stress (PSWS).

Main Results:

  • Preserved systolic function with increased PSWS in EHT without LVH.
  • LVH advanced with preserved systolic function in one group; negative T-waves indicated issues in advanced stages.
  • Afterload mismatch was identified in advanced EHT with heart failure (group III) due to preload reserve exhaustion, with an LVM index boundary around 180 g/m².

Conclusions:

  • Afterload mismatch is absent in early essential hypertension without LVH.
  • Afterload mismatch occurs in advanced EHT with LVH and heart failure, linked to the exhaustion of preload reserve.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
31
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
38
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
489
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
38
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K